SecBot SecBot
SECBOTREPLAY Home › Report › ANIP

ANIP · A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil…

ANI PHARMACEUTICALS INC · CLUSTER filed May 10, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed May 10, 2026 at 20:00 ET

A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.

  • CEO Nikhil Lalwani sold 55,000 shares for $4.27M on May 11, 2026.
  • Director Patrick Walsh sold a total of ~14,000 shares for $1.13M over May 11-13.
  • Total insider sales in the cluster: ~$5.7M, or ~0.3% of ANIP's $1.8B market cap.
  • Q1 2026 revenue was $237.5M (+20.5% YoY), beating consensus of $207.6M.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access